pI: 4.9329 |
Length (AA): 651 |
MW (Da): 74734 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Ortholog group members (OG5_128675)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G28030 | DNA repair protein UVH3 |
Babesia bovis | BBOV_II000500 | Rad2 endonuclease, putative |
Brugia malayi | Bm1_05790 | XPG N-terminal domain containing protein |
Candida albicans | CaO19.1324 | similar to RAD13, excision repair protein |
Candida albicans | CaO19.8904 | similar to RAD13, excision repair protein |
Caenorhabditis elegans | CELE_F57B10.6 | Protein XPG-1 |
Cryptosporidium hominis | Chro.40058 | RAD2 |
Cryptosporidium parvum | cgd4_440 | XPG, DNA excision repair protein, flap endonuclease |
Dictyostelium discoideum | DDB_G0294290 | xeroderma pigmentosum group G family protein |
Drosophila melanogaster | Dmel_CG10890 | mutagen-sensitive 201 |
Echinococcus granulosus | EgrG_000321400 | DNA repair protein complementing XP G cells |
Entamoeba histolytica | EHI_100400 | DNA-repair protein, putative |
Echinococcus multilocularis | EmuJ_000321400 | DNA repair protein complementing XP G cells |
Homo sapiens | ENSG00000270181 | BIVM-ERCC5 readthrough |
Homo sapiens | ENSG00000134899 | excision repair cross-complementation group 5 |
Loa Loa (eye worm) | LOAG_00986 | hypothetical protein |
Mus musculus | ENSMUSG00000026048 | excision repair cross-complementing rodent repair deficiency, complementation group 5 |
Neospora caninum | NCLIV_037790 | RAD2 endonuclease, putative |
Oryza sativa | 4331991 | Os03g0205400 |
Plasmodium berghei | PBANKA_0303700 | DNA repair protein RAD2, putative |
Plasmodium falciparum | PF3D7_0206000 | DNA repair protein RAD2, putative |
Plasmodium knowlesi | PKNH_0414900 | DNA repair protein RAD2, putative |
Plasmodium vivax | PVX_003735 | DNA repair protein RAD2, putative |
Plasmodium yoelii | PY01122 | XPG I-region, putative |
Saccharomyces cerevisiae | YGR258C | Rad2p |
Schistosoma japonicum | Sjp_0023590 | DNA-repair protein rad13, putative |
Schistosoma mansoni | Smp_123940 | xp-G/rad2 DNA repair endonuclease family |
Schmidtea mediterranea | mk4.006295.00 | |
Schmidtea mediterranea | mk4.005914.00 | |
Toxoplasma gondii | TGME49_268560 | XPG N-terminal domain-containing protein |
Theileria parva | TP04_0530 | DNA repair protein rad2, putative |
Theileria parva | TP04_0531 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_046610 | flap endonuclease-1, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
CELE_F57B10.6 | Caenorhabditis elegans | embryonic lethal | wormbase |
PBANKA_0303700 | Plasmodium berghei | Dispensable | plasmo |
TGME49_268560 | Toxoplasma gondii | Essentiality uncertain | sidik |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | excision repair cross-complementation group 5 | Compounds | References |